What the study found
The authors argue that metabolic reprogramming of the gut microbiota may be an early pathogenic event in systemic metabolic diseases. They describe this as a process in which imbalances in the gut microbiota lead to changes in lipid, glucose, amino acid, and uric acid metabolism.
Why the authors say this matters
The study suggests that this concept helps explain how gut microbiota dysbiosis may contribute to metabolic disorders before host disease onset. The authors conclude that this framework may refine the understanding of metabolic disease and point to new possibilities for targeting the microbiome in prevention and treatment.
What the researchers tested
This is a review article. The authors introduce the concept of gut microbiota metabolic reprogramming and organize existing evidence into a model linking gut microbiota imbalance, metabolic changes, and systemic metabolic disease.
What worked and what didn't
The review presents a coherent model in which gut microbiota metabolic reprogramming is linked to changes in lipid, glucose, amino acid, and uric acid metabolism, along with host metabolic and immune homeostasis. It also states that the mechanisms behind these gut microbiota changes remain poorly understood.
What to keep in mind
The abstract does not describe new experimental data, and it does not provide specific study limitations beyond noting a knowledge gap. The summary is limited to the concepts and claims stated in the abstract.
Key points
- The authors propose that gut microbiota metabolic reprogramming may occur early in systemic metabolic disease.
- Gut microbiota imbalance is described as affecting lipid, glucose, amino acid, and uric acid metabolism.
- The study suggests these changes may help regulate host metabolic and immune homeostasis.
- The authors say the mechanism of gut microbiota metabolic reprogramming remains poorly understood.
- The paper proposes the microbiome as a possible target for prevention and treatment of metabolic disorders.
Disclosure
- Research title:
- Gut microbiota metabolic reprogramming may drive metabolic disease
- Authors:
- Yanrong Wang, Beibei Huang, Xue Wei, Yuanyuan Guan, Lingru Li, Yanfei Zheng, Wenlong Sun
- Institutions:
- Shandong University of Technology, Beijing University of Chinese Medicine
- Publication date:
- 2026-03-14
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.